Safety and Immunogenicity of SW-BIC-213, a Modified COVID-19 Lipo-Polyplex mRNA Vaccine, in Laotian Healthy Adults Aged 18 Years and Above: A Phase 1/2 Trial.

Yuan Y, Zeng Y, Zhu M, Sun Z, Xu W, Hu Y, Liu G, Shen M, Yang C, Gao D

Open source

DOI: 10.3390/vaccines14080708
Published: 2026 Aug 18
Container: Vaccines
Publisher: Not recorded
Open access: yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
supportingDirectory of Open Access Journals: A matching record was returned by DOAJ. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.3390/vaccines14080708,
  title = {Safety and Immunogenicity of SW-BIC-213, a Modified COVID-19 Lipo-Polyplex mRNA Vaccine, in Laotian Healthy Adults Aged 18 Years and Above: A Phase 1/2 Trial.},
  author = {Yuan Y and Zeng Y and Zhu M and Sun Z and Xu W and Hu Y and Liu G and Shen M and Yang C and Gao D},
  year = {2026},
  journal = {Vaccines},
  doi = {10.3390/vaccines14080708},
  url = {https://doi.org/10.3390/vaccines14080708}
}

RIS

TY  - JOUR
TI  - Safety and Immunogenicity of SW-BIC-213, a Modified COVID-19 Lipo-Polyplex mRNA Vaccine, in Laotian Healthy Adults Aged 18 Years and Above: A Phase 1/2 Trial.
AU  - Yuan Y
AU  - Zeng Y
AU  - Zhu M
AU  - Sun Z
AU  - Xu W
AU  - Hu Y
AU  - Liu G
AU  - Shen M
AU  - Yang C
AU  - Gao D
PY  - 2026
JO  - Vaccines
DO  - 10.3390/vaccines14080708
UR  - https://doi.org/10.3390/vaccines14080708
ER  -

APA

Y, Y., Y, Z., M, Z., Z, S., W, X., Y, H., G, L., M, S., C, Y., & D, G. (2026). Safety and Immunogenicity of SW-BIC-213, a Modified COVID-19 Lipo-Polyplex mRNA Vaccine, in Laotian Healthy Adults Aged 18 Years and Above: A Phase 1/2 Trial.. Vaccines. https://doi.org/10.3390/vaccines14080708

Source records

pubmed · retrieved 2026-09-26T01:42:33.582Z
europe-pmc · retrieved 2026-09-26T01:42:33.591Z
doaj · retrieved 2026-09-26T01:42:33.626Z